RIFF|3WEBPVP8X eVP8 8]*f>%B!>, K ?Qkp~{ϖ?{~CzWZ'O/6/\z>x?1o?xߑ9]֛?}ϳ=*[<_O~|%qGo/?=%nKVs1wRJAEVCb,u.8'pHA:ٕ]@TA%vJsfL8q;IOfur;=" 3=t}w1 쫖W4E漄_Xn A;3 / ahm0VQt8 XT`&hu}ZC93^B+NT0w*i9WEbyp)R6#%V? .y0=,ݸҥĎYDb5 ^G?[n!Dh\zVJپzDHᬎQWn6O䑆lj  ۧ%/+ my(0l^=fൺ> *okC=x 'bTl|_WP4@떦Sy(ٱɜR [s҅-_rMo0ŚdadklrS_i4qhMM.̄SL07&,P-wXDFYHKnKӌS=yc4Gj9} +wWQ"V/ln'UEn-8͒xdӂu&6~u]+(VW\a=OŲ x1S筅\vAYOmTgs0G&!AYаdd557 rU vD.V;d7U{3,k|'^Z\1 q. ymB\xrݚg-ﹸ*aUAPhe/Z Ф @*mӋMJWݰ*.WC*i5vբ`B( . i?fVb0mb% ;0$:MSc$Jn:ב^ XxEpo{V^UfLD}Q)e9IGRKc,^kXzqM9wjl}]F90:*bohPT8WӠ5 4c`b1ԮCCUtOWr}|T;߁kZs`E mm`ƒIY̒+ |Xɞ ~S Q:^s#{uA“?~Ӈ3I"/TC5]o:bq簤՞ ]IhfUϭC !6phb3tl baB ڌ{lńALo4]|[\IëC~L0P5W8gf:iEW'p;f?xZ 7tDqZ󴫵rpJ[lQ~6čnջ+%I+"f[5B>៑ud2`oZ3D|dQ@?Ș`3(*KSz)ϯt擧ZWzED5pC/R>ʹߙzVxD("cչմ59G::f-qbi a"<cvaͷK:F,ld``Gr/)qN??>fzgWTmfj~E>HU{_>8mRo S:K[JsJcl6n& p!PE8٤b=]>_^}O*%(G"u!w i_--uWQ4p 6_SU/C{XTf~=pZ]V$ӆg v b\"m>O/+m{+ΉD-a߀hΎXhoު7=#@m,*I1dnUZ"uL n%S\ Z XNıL Or$haRq4*NeVd%U94ZMQRDFi|=lWR'7+B +؅>zb9&ߨn$u7皁뇻 c{ '}&.ESC;#緧9n?͏R(Y$o{haZSN(<#,!5 =@Niyu楟1SRbTMoѩY#UTDu! EZwߑ}[dXhrT̢ryJH+c~,\G2E+'dthh73XslxM ݷ<_ y>߸v5SV:;hU {lȀL5D}[]#Ie͜ W\&vs|Lt"H !{}zCC"n9>mNy!:ڝ.޹b=(WB?~me[ wU0b j"MJJ-qG1n ؛:O.猃F8κϠA% nm7hS'q51:WF$s<[pD Xk1׀@L΁y0-; ]Zպq*^ҖjڽGfM.w( jVNxµ 7e'TZK9;뇘ϦiҩbExD ƾ.4mi֖–A+N/8}.yRW?㧸0ޛ T2(e_ $n/}p1G,{#Z;~}MwL7AK%b w*xC1&*~T{6^T\]Xl)['tF42eҨ9:"{)٬pk]zȞw%u)+7! En E&5N>/+aݤP%.whz>,c0\G]Ja/nED=SثiLP5-s sxŢ>A8|u:J\ 9u05r[ÀD-ē qgQ\37p wWe,1/8wGjsd^Ujҹt֢>ͯ`򦭧y`p1a(װu4s7a: t Rw6ƌ8G4l]ú9dYO M&njh@:F^PU\ih$: *Cd|YZnh:܈GrdFAxG0jԳy75I2 L %fJ4ى°PՆԽ'J5G2%|&b.\P&/Z(Tr5Az }++ c>3Q,],If]{ +"sv^Մ@"3+ZQ ׼b} !2JgoXr09u{\mw_4YSPP) w r@{ob69c P8NGZ %9XMP 2021-04-26T16:39:59-04:00 2021-05-21T12:46:01-04:00 2021-05-21T12:46:01-04:00 Adobe InDesign 16.1 (Macintosh) uuid:8fecf034-159d-bb4c-a9b8-6d02a4e5a4c3 xmp.did:a75a9617-2bd2-43f8-9ffa-6c46e9900a23 xmp.id:be7fd491-4e6a-4b09-bbfb-18edc7d57893 proof:pdf xmp.iid:0de7fab2-fb7d-4943-9146-dcc8aa17b1dd xmp.did:236084f3-f1a0-4015-b68f-53b98770311e xmp.did:a75a9617-2bd2-43f8-9ffa-6c46e9900a23 default converted from application/x-indesign to application/pdf Adobe InDesign 16.1 (Macintosh) / 2021-04-26T16:39:59-04:00 application/pdf Regeneron Annual Report 2020 Annual Report 2020 Regeneron Regeneron Pharmaceuticals Inc. 2020 Shareholders Infectious Diseases Ophthalmology Immunology & Inflammation Oncology Classical Hematology Cardiovascular Diseases Rare Diseases Advances in Technology Strategic Business Approaches Forward-looking statements and non-GAAP financial measures Adobe PDF Library 15.0 False Regeneron Pharmaceuticals, Inc., 2020, Shareholders, Infectious Diseases, Ophthalmology, Immunology & Inflammation, Oncology, Classical Hematology, Cardiovascular Diseases, Rare Diseases, Advances in Technology, Strategic Business Approaches, Forward-looking statements and non-GAAP financial measures